Odyssean LLC’s Integra LifeSciences IART Stock Holding History

Odyssean LLC’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,089	Closed	-$123K	–	526
2026 Q1	$123K	Buy	+13,089	New	+$144K	0.05%	403

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Odyssean LLC's IART Position: Q2 2026 in Review

Odyssean LLC sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 13,089 shares — an estimated $123K sold.

Odyssean LLC first reported a position in IART in Q1 2026 and held it in 1 quarter. The position peaked at $123K in Q1 2026. 211 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Odyssean LLC reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
Odyssean LLC sold 13,089 Integra LifeSciences shares in Q2 2026, an estimated $123K.
Odyssean LLC first reported a position in Integra LifeSciences in Q1 2026 and held it in 1 quarter.
Odyssean LLC's Integra LifeSciences position peaked at $123K in Q1 2026.
211 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.